DYNA-HEX 4
LOE Approachingchlorhexidine gluconate 4%
NDATOPICALSOLUTION
Approved
Dec 1984
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
DYNA-HEX 4 (chlorhexidine gluconate 4%). Approved for bacteria, general skin cleansing. First approved in 1984.
Drug data last refreshed 5d ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DYNA-HEX 4 is a topical chlorhexidine gluconate 4% solution indicated for bacterial skin cleansing and general antimicrobial skin preparation. It is a broad-spectrum antiseptic that reduces microbial burden on skin surfaces. Typical use includes pre-operative skin preparation and wound cleansing in healthcare settings.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30%); expect defensive positioning and team focus on market share retention rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications (2)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.